The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII
Open accessAbstract
Key Points: Generation and functional analysis of FVIII-specific human CAR Tregs. Specific regulation of FVIII responses by engineered human CAR Tregs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, multiple studies generated transgene-specific CAR Tregs, which showed promising results in suppression of transgene-induced immune responses [235–237].”
From Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer (2023) · cites this paper as [235]
Citations
Cites
Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific
Thornton, A. M., & Shevach, E. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.183 · Cited by 1,229
The hemophilias--from royal genes to gene therapy
Mannucci, P. M., & Tuddenham, E. G. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442307 · Cited by 1,110
Brunstein, C. G., Miller, J. S., Cao, Q., McKenna, D. H., Hippen, K. L., Curtsinger, J., DeFor, T., Levine, B. L., June, C. H., Rubinstein, P., et al. (2011) · Blood · doi:10.1182/blood-2010-07-293795 · Cited by 1,045
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor
Maher, J., Brentjens, R. J., Gunset, G., Rivière, I., & Sadelain, M. (2002) · Nature Biotechnology · doi:10.1038/nbt0102-70 · Cited by 1,034
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
Ellebrecht, C. T., Bhoj, V. G., Nace, A., Choi, E. J., Mao, X., Cho, M. J., Di Zenzo, G., Lanzavecchia, A., Seykora, J. T., Cotsarelis, G., et al. (2016) · Science · doi:10.1126/science.aaf6756 · Cited by 738
Trzonkowski, P., Bieniaszewska, M., Juścińska, J., Dobyszuk, A., Krzystyniak, A., Marek, N., Myśliwska, J., & Hellmann, A. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.06.001 · Cited by 683
Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A
Bi, L., Lawler, A. M., Antonarakis, S. E., High, K. A., Gearhart, J. D., & Kazazian, H. H. (1995) · Nature Genetics · doi:10.1038/ng0595-119 · Cited by 593
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
MacDonald, K. G., Hoeppli, R. E., Huang, Q., Gillies, J., Luciani, D. S., Orban, P. C., Broady, R., & Levings, M. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82771 · Cited by 494
IORIO, A., HALIMEH, S., HOLZHAUER, S., GOLDENBERG, N., MARCHESINI, E., MARCUCCI, M., YOUNG, G., BIDLINGMAIER, C., BRANDAO, L. R., ETTINGSHAUSEN, C. E., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03823.x · Cited by 279
Cited by
Treg cell-based therapies: challenges and perspectives
Raffin, C., Vo, L. T., & Bluestone, J. A. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0232-6 · Cited by 720
Universal Chimeric Antigen Receptors for Multiplexed and Logical Control of T Cell Responses
Cho, J. H., Collins, J. J., & Wong, W. W. (2018) · Cell · doi:10.1016/j.cell.2018.03.038 · Cited by 682
“Current CAR-based therapy is typically implemented in a cell mixture (e.g., peripheral blood mononuclear cells) or single subsets of immune cell types (e.g., CD4+, CD8+, Treg, or NK cells; Glienke et al., 2015; Klingemann, 2014; MacDonald et al., 2016; Yoon et al., 2017).”
Next-generation regulatory T cell therapy
Ferreira, L. M. R., Muller, Y. D., Bluestone, J. A., & Tang, Q. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0041-4 · Cited by 476
CAR T cells for infection, autoimmunity and allotransplantation
Maldini, C. R., Ellis, G. I., & Riley, J. L. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0042-2 · Cited by 229
Gene editing for immune cell therapies
Bailey, S. R., & Maus, M. V. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0137-8 · Cited by 203
Metadata
- Authors
- Yoon, J., Schmidt, A., Zhang, A.-H., Königs, C., Kim, Y. C., & Scott, D. W.
- Affiliations
- Uniformed Services University of the Health Sciences (US)
- Goethe University Frankfurt (DE)
- Corresponding author
- Yoon, Jeongheon
- Schmidt, Anja
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2017-01-12
- Volume
- 129
- Issue
- 2
- Pages
- 238-245
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC5234219
- OpenAlex
- W2555431842
- Cited by
- 150
- References
- 22
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 9 · 2023: 13 · 2022: 15 · 2021: 13 · 2020: 18 · 2019: 13 · 2018: 27 · 2017: 17
- FWCI
- 18.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R56HL061883, R01HL126727, R01HL061883)
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Keywords
- factor VIII, hemophilia A, chimeric antigen receptor, regulatory T cells, immune tolerance induction, factor VIII inhibitors, antibody response suppression, bystander suppression, T cell receptor engineering, tolerogenic therapy
- MeSH terms
- Animals, B-Lymphocytes, Factor VIII, Flow Cytometry, Humans, Immunosuppression Therapy, Lymphocyte Activation, Receptors, Antigen, T-Cell, Transduction, Genetic, Mice, Knockout, T-Lymphocytes, Regulatory, Mice, Cell Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII. https://app.cochat.ai/papers/10.1182/blood-2016-07-727834
- The paper
- Yoon, J., Schmidt, A., Zhang, A.-H., Königs, C., Kim, Y. C., & Scott, D. W. (2017). FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII. Blood. https://doi.org/10.1182/blood-2016-07-727834
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.